| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 4.64 | -0.10 (-2.09%) | 4.01 - 7.95 | 7.1 thousand (Below Avg) |
Market data as of 3:59PM 05/17/13. Quotes are delayed by at least 15 min.
| Open | 4.78 |
|---|---|
| Previous Close | 4.74 |
| Day's Range | 4.60 - 4.78 |
| Market Cap | 31.8M |
| Avg Volume (10 Day) | 16.5K |
| Price/Earnings (Trailing 12 Mo.) | 18.6x |
| Earnings Per Share (Trailing 12 Mo.) | 0.25 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
Natural Alternatives International, Inc. Announces Fiscal 2013 Q3 and YTD Results
PR Newswire - Tuesday 05/14/2013 4:30 PM ET
| NAII | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 0.84% | |
| Net Income Growth (1yr) | -73.10% | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | 5.38% | |
| Price/Sales | 0.48 |
| Company | Last | Change |
|---|---|---|
| Cyanotech Corp | 5.59 | -0.18% |
| ProPhase Labs Inc | 1.58 | +0.86% |
| Nature's Sunshine Products Inc | 15.31 | +1.26% |
| LifeVantage Corp | 2.44 | +1.24% |
| Auxilium Pharmaceuticals Inc | 15.01 | -0.27% |
Data is delayed by at least 15 min.